Journal Home
Search for

Volume 82, Issue 8, Pages 1073-1080 (August 2001)


View previous. 10 of 22 View next.

Recovery from moderate aphasia in the first year poststroke: Effect of type of therapy☆☆★★♢♢

Sergio Carlomagno, MD, FRCP, Maria Pandolfi, MD, Ludovica Labruna, MCSP, SRP, Anna Colombo, MD, Carmelina Razzano, MCSLT

Accepted 20 October 2000.

Abstract 

Carlomagno S, Pandolfi M, Labruna L, Colombo A, Razzano C. Recovery from moderate aphasia in the first year poststroke: effect of type of therapy. Arch Phys Med Rehabil 2001;82:1073-80. Objectives: (1) To determine whether 2 model-based remediation programs affect writing performance in unselected subjects with moderate aphasia and whether there is consequent improvement in everyday life, and (2) to interpret the potential changes observed by recourse to a theoretical model. Design: Consecutive sample, multiple baseline, within subject crossover study. Setting: Ambulatory care units. Participants: Eight subjects with moderate aphasia from 6 to 12 months postonset. Intervention: A standardized test for reading and writing skills was given at the beginning and the end of each therapy program and 1 month after therapy stopped. Main Outcome Measures: Functional outcome measures were the Communicative Abilities in Daily Living (CADL) test and subtests from standardized aphasia assessment. Results: After the 2 programs, there was improved writing performance, which was maintained after therapy stopped. Patterns of improvement corresponded to each of the 2 programs. Learning transfer was observed on the CADL test and functional writing, but gains on oral language were limited. Only 1 program was effective for 6 of the 8 patients. Conclusion: Specific rehabilitation programs aid recovery from aphasic symptoms from 6 to 12 months postonset. Individual response is linked to type of treatment. The interpretation is linked to a model-based description of aphasic symptoms and mechanisms of functional recovery. © 2001 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation

Istituto di Scienze Neurologiche, Seconda Università di Napoli, Napoli (Carlomagno, Pandolfi, Labruna, Colombo); and IRCCS Santa Lucia, Roma (Razzano), Italy

 Supported by grants from the Ministero Università e Ricerca Scientifica e Tecnologica and the IRCCS Santa Lucia, Roma.

☆☆ No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

 Reprint requests to Sergio Carlomagno, MD, FRCP, Instituto di Scienze Neurologiche, Seconda Università di Napoli, Via Pansini 5 (Padiglione 10) 80131 Napoli, Italy, e-mail: sergio.carlomagno@unina2.it.

★★ Suppliers

 a. SAS Institute Inc, SAS Campus Dr, Cary, NC 27513.

♢♢ b. Apple Computers Inc, One Inifinite Loop, Cupertino, CA 95014.

 c. Centers for Disease Control and Prevention, Epidemiology Program Office, Division of Public Health Surveillance and Informatics, 1600 Clifton Rd, Atlanta, GA 30333.

PII: S0003-9993(01)77581-8

doi:10.1053/apmr.2001.25155


View previous. 10 of 22 View next.